ArticleNPJ digital medicine2026
Noninvasive PPROM risk stratification with explainable AI using routine antenatal CRP and albumin.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Premature rupture of membranes (PROM) and preterm PROM (PPROM) are significant obstetric complications, affecting 10-20% and 3% of pregnancies globally and constituting a major cause of preterm birth and neonatal morbidity. While intrauterine infection is a key underlying driver, timely identification of high-risk cases remains a clinical challenge. We developed a noninvasive artificial intelligence (AI) predictive framework using a large-scale dataset of 114,601 antenatal laboratory and ultrasound measurements. Our multimodal model integrated longitudinal clinical measures, including maternal demographics, laboratory results, and ultrasound data. The optimized XGBoost algorithm achieved high performance (AUC: 0.952) and identified elevated C-reactive protein (CRP) and decreased albumin levels in late pregnancy as top features, underscoring the critical roles of inflammation and oxidative stress. SHAP analysis ensured interpretability, unveiling dynamic risk patterns across gestation. This AI-driven approach provides a precise, noninvasive tool for late-gestation PPROM risk stratification, paving the way for translation into precision obstetric care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.